Peaches Biotech Group
IN THE SERVICE OF HEALTH AND BIOTECHNOLOGY
Peaches Biotech Group works to transfer the most relevant advances in science and health technology to the citizens, in order to contribute to the development and welfare of society.
What we include
The Peaches Group is made up of professionals and companies involved in science, technology and innovation in health, collaborating with various foundations and research groups, one of which is the University Hospital of Fuenlabrada, where it is present with the Bioincubator of companies specializing in Advanced Cell Therapy; Living Cells, a pioneering agreement in Spain for public-private collaboration.
The Peaches Biotech team is formed by different multidisciplinary professionals linked to science and technology in health.
President of Cardiva and Cardivais
Ignacio Vega is a member of the Board of Directors of Grupo Peaches.
He began his professional career in the healthcare technology sector at Medtronic in 1977. Curiosity and a background in economics led him to found MedTech in 1982. Subsequently, in 1988, he launched Cardiva and, in 2002, Cardivais. More than three decades later, work continues to define his life, always from a conscious and humane perspective. Perseverance, confidence in the team and the desire to excel have marked his career. He is also a member of the Board of Directors of iVascular and Histocell.
Dr. Juan Pedro Lapuente
Scientific Director of Peaches Biotech
Dr. Lapuente is the Scientific Director of the Peaches Group. Prestigious physician expert in Regenerative Medicine, he has a degree in Medicine and Surgery, Official European Master in Transfusion Medicine and Advanced Cellular Therapies, Master in Sports Traumatology, Master in Molecular and Cellular Biology and Doctorate in Medicine at UCAM in 2018.
He joined Peaches Group in 2017, where he leads the R&D+i department in the field of research on new technologies applied to biotechnology and Regenerative Medicine.
Dr. Pedro Lapuente is in constant contact with medical teams from leading national and international hospitals, as well as top sports clubs throughout Europe, helping to advocate for the new medical technologies developed by the Peaches Group.
A speaker and thought leader at multiple scientific events, he has received numerous awards for recent advances in the field of research.
Juan Carlos de Gregorio
CEO of Peaches Biotech Group
Degree in Pharmacy (Specialization in Food Technology and Enzymology and Industrial Galenics), Executive M.B.A. (IESE) and professor at the Official College of Pharmacists of Madrid.
With more than 30 years of experience in pharmaceuticals, biotechnology, biomedicine and healthcare, as well as extensive experience as an entrepreneur, with strong leadership and team skills.
In 2005, he received the IESE-Vocento- Ernst&Young Innovation Award.
He was also Founder and CEO of Exxentia, a company that became a leader in Europe in the sale of raw materials for the production of medicinal plants, basing its success on research, being integrated into Puleva Biotech in 2008, with De Gregorio joining the Management Committee of the Ebro – Puleva Group.
At Grupo Andrómaco he was Technical Pharmaceutical Director and Director of Marketing.
We work to transfer the most relevant advances in health science and technology to citizens, in order to contribute to the development and welfare of society.
At the service of health and biotechnology
Always within the framework of innovation and the latest medical and scientific technologies that bring quality of life to people.
C/ Isabel Colbrand 6
4th Floor B
28050 Madrid (Spain)
M – Th : 9 :00-18:00 hs
F : 9 :00-15:00 hs